The Ewing Marion Kauffman Foundation today announced the appointment of Victor W. Hwang as vice president of entrepreneurship. Hwang will relocate from California to Kansas City to lead the Foundation’s renowned entrepreneurship programming. He starts on Feb. 29.
The median pay among STEM workers in 2014 was more than $72,000. That’s more than double the median income among all occupations, according to Bureau of Labor Statistics data. Few would argue, however, that STEM workers are generally overpaid. Experts in the fields of science, technology, engineering and math are key contributors to economic growth. Furthermore, STEM occupations generally require years of rigorous and difficult training.
I’m not sure about you, but I’m getting tired of Steve Jobs. Sure, he was an innovation icon. But, in my view, the media and pundits are creating unrealistic expectations hyping and promoting the Jobs/Branson/Musk iconography.
Yumanity Therapeutics, a drug developer focused on diseases caused by protein misfolding, has raised $45 million in Series A funding. Fidelity Management & Research Company led the round with participation from Redmile Group, Alexandria Venture Investments, Biogen, Sanofi-Genzyme BioVentures and Dolby Family Ventures.
Bobby Gattuso became a startup founder while an undergraduate at Towson University.
Hop Theory’s sachets that bring beer up to craft levels got early traction through Kickstarter and national press hits.
A senior Google executive, Jeff Huber, will become the CEO of Grail, the high-profile company launched in January to develop and commercialize cancer blood tests.
According to Forbes, Huber’s wife, Laura, died from colon cancer last November, leaving behind two teenage children. “That’s a big part of why I’m taking this up,” Huber told the magazine.
“You are cordially invited to the “SBIR and STTR Federal Funding Mechanisms for Improving the Reach of Behavioral Science” seminar at the Society of Behavioral Medicine (SBM) 2016 Annual Meeting & Scientific Sessions. National Cancer Institute SBIR (NCI SBIR) Development Center Program Director Dr. Patricia Weber will be leading the seminar with presenters from NIH, including NCI and NHLBI, a HealthTech investment CEO and a small business entrepreneur. The session will include a range of topics such as an overview of the SBIR/STTR program goals, how NCI and NHLBI work to help with the commercialization process, how SBIR/STTR funding can advance behavioral science, investor perspectives on behavioral health products, and perspectives from an awardee.”
It’s comforting to believe that the world of venture funding is a meritocracy.
It’s comforting to believe that a founder has a good idea, pitches successfully and gets money from a VC to turn said idea into a business.
10x Genomics has announced two new sequencing partnerships with Qiagen and Illumina.
Yesterday, 10x said that it is partnering with Qiagen to co-develop and co-market next-generation sequencing and single-cell biology analysis workflows and informatics solutions.
Enterprising startups are disrupting incumbent players in industries as diverse as publishing, entertainment and personal finance. Healthcare is far from immune to this tech-driven business trend— across the industry, young and innovative firms are giving legacy systems a run for their money.
At the heart of the change sweeping across the healthcare business is data.
